Regional White Matter Integrity Predicts Treatment Response to Escitalopram and Memantine in Geriatric Depression: A Pilot Study
Background: Geriatric depression with subjective memory complaints increases the risk for Alzheimer's Disease. Memantine, a neuroprotective drug, can improve depression and help prevent cognitive decline. In our 6-months clinical trial, escitalopram/memantine (ESC/MEM) improved mood and cogniti...
Main Authors: | Beatrix Krause-Sorio, Prabha Siddarth, Michaela M. Milillo, Roza Vlasova, Linda Ercoli, Katherine L. Narr, Helen Lavretsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2020.548904/full |
Similar Items
-
Memantine add on to citalopram in elderly patients with depression: A double-blind placebo-controlled study
by: Victoria Omranifard, et al.
Published: (2014-01-01) -
Evaluation of the Effect of Memantine Supplementation in the Treatment of Acute Phase of Mania in Bipolar Disorder of Elderly Patients: A Double-blind Randomized Controlled Trial
by: Victoria Omranifard, et al.
Published: (2018-01-01) -
Default mode network connectivity and treatment response in geriatric depression
by: Lisa A. Kilpatrick, et al.
Published: (2022-04-01) -
Memantine: Reality and Potentiality
by: Rodolfo M. Antonello, et al.
Published: (2008-01-01) -
Maniform episode related to memantine therapy: unraveling of an unknown adverse side effect?
by: Catarina da Costa Campos, et al.
Published: (2021-08-01)